
Quadriga sells Alicona Imaging to Bruker

Quadriga Capital has sold porfolio company Alicona Imaging, an Austrian measuring technology company, to US trade buyer Bruker Corporation.
No terms were disclosed, and the transaction is still subject to customary merger control approval.
Bruker is a US-based maker of scientific instruments, listed on Nasdaq with a $5bn market cap. It highlighted that Alicona's technology and products would be complementary to its existing range, while Alicona stated it would be able to tap Bruker's extensive distribution network as part of the merger.
Quadriga acquired a majority stake in Alicona in 2015. The private equity firm stated at the time that it intended to implement an internationalisation strategy. No financial details surrounding the deal were released.
Quadriga mandated Alantra to run the sale process, which was geared towards international strategic acquirers.
Company
Founded in 2001, Alicona manufactures optical 3D surface metrology systems for quality assurance purposes. Its technology is used to develop products and processes in the machine tool industry and for medical technology, forensic science and microelectronics. The Graz-based company also operates in Germany, France, the UK, the US, South Korea and Italy.
People
Quadriga Capital – Philipp Jacobi (managing partner).
Advisers
Equity – Alantra (corporate finance).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater